TORRENT PHARMACEUTICALS
Back to Income Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹2,163 Cr | ₹1,911 Cr | ₹1,656 Cr | ₹1,245 Cr | ₹777 Cr |
What is the latest Consolidated Net Profit of TORRENT PHARMACEUTICALS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹2,163 Cr |
| Mar2025 | ₹1,911 Cr |
| Mar2024 | ₹1,656 Cr |
| Mar2023 | ₹1,245 Cr |
| Mar2022 | ₹777 Cr |
How is Consolidated Net Profit of TORRENT PHARMACEUTICALS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,163 Cr | 13.19 | |
| Mar2025 | ₹1,911 Cr | 15.39 | |
| Mar2024 | ₹1,656 Cr | 33.02 | |
| Mar2023 | ₹1,245 Cr | 60.22 | |
| Mar2022 | ₹777 Cr | - | |
Compare Consolidated Net Profit of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹192,703.0 Cr | 6.3% | 12.2% | 45.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,842.0 Cr | 1.1% | 4.6% | 14.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,860.0 Cr | 0.6% | 8.3% | 8.2% | Stock Analytics | |
| CIPLA | ₹112,593.0 Cr | -1.7% | -2.8% | -4% | Stock Analytics | |
| MANKIND PHARMA | ₹105,607.0 Cr | 2.6% | 1.1% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,364.9 Cr | -3.7% | -10.4% | -6% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 6.3% |
12.2% |
45.5% |
| SENSEX | -1% |
-0.9% |
-7.5% |
You may also like the below Video Courses